MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

naxolone

  • FDA Approves Opioid Overdose Drug Naloxone From Nonprofit Company
    FDA Approves Opioid Overdose Drug Naloxone From Nonprofit Company
    The Food and Drug Administration (FDA) on Friday approved an opioid overdose drug for over-the-counter (OTC) use from a nonprofit company. The FDA has granted approval to RiVive, manufactured by Harm ...
    July 28, 2023BY Caden Pearson
  • Fentanyl Overdose Antidote Gets Fast Tracked Review by FDA, Company Says
    Fentanyl Overdose Antidote Gets Fast Tracked Review by FDA, Company Says
    The U.S. Food and Drug Administration (FDA) will give priority status to an over-the-counter opium overdose antidote nasal ...
    December 27, 2022BY Caden Pearson
TOP NEWS
  • FBI Operation Summer Heat Results in Over 4,000 Arrests
    NEW By Naveen Athrappully
    FBI Operation Summer Heat Results in Over 4,000 Arrests
  • Flock Announces Platform Changes After Public Backlash to Its Camera Network
    NEW By Jacob Burg
    Flock Announces Platform Changes After Public Backlash to Its Camera Network
  • US Ambassador to Israel Condemns Settler Violence Against Palestinian Homes in West Bank
    NEW By Jackson Richman
    US Ambassador to Israel Condemns Settler Violence Against Palestinian Homes in West Bank
  • Judge Dismisses DOJ’s Anti-Semitism Lawsuit Against Harvard
    NEW By Jacki Thrapp
    Judge Dismisses DOJ’s Anti-Semitism Lawsuit Against Harvard
  • Sunshine, Soccer Give UK Economy Summertime Spur
    1hr By Guy Birchall
    Sunshine, Soccer Give UK Economy Summertime Spur
  • Iran Cites Environmental Damage in Push for Hormuz Shipping Fees
    2hr By Tom Ozimek
    Iran Cites Environmental Damage in Push for Hormuz Shipping Fees
  • US Military Intervention in Cuba ‘On the Table,’ Hegseth Says
    2hr By Ryan Morgan
    US Military Intervention in Cuba ‘On the Table,’ Hegseth Says
  • 10 States Sue to Block Federal Mortgage Escrow Interest Rules
    2hr By Bill Pan
    10 States Sue to Block Federal Mortgage Escrow Interest Rules
  • Japan Protests as Putin Visits Disputed Islands
    2hr By Chris Summers
    Japan Protests as Putin Visits Disputed Islands
  • Trump Says US Has ‘Total Control’ of Hormuz
    4hr By Tom Ozimek
    Trump Says US Has ‘Total Control’ of Hormuz
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top